Oyster Point Pharma Inc. (OYST) NASDAQ

$11.17 - (-)

Market Cap: -

As of 12/30/22 12:00 AM EST. Market closed.

(OYST)

Oyster Point Pharma Inc. (OYST)
NASDAQ

$11.17
- (-)

Market Cap: -

As of 12/30/22 12:00 AM EST. Market closed.

Add to Portfolio

Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharma's lead product candidate, OC-01 (varenicline) nasal spray, a highly selective cholinergic agonist, is being developed as a nasal spray to treat the signs and symptoms of dry ... read more

Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharma's lead product candidate, OC-01 (varenicline) nasal spray, a highly selective cholinergic agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. In pre-clinical and clinical studies, OC-01 (varenicline) nasal spray was shown to have a novel mechanism of action via activation of the trigeminal parasympathetic pathway to stimulate the glands and cells responsible for natural tear film production, known as the lacrimal functional unit. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
62
Address
.
PRICE CHART FOR OYSTER POINT PHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$11.17
Days Range
$11.12 - $11.20
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
26,844,292
Open
-
Previous Close
$11.17
Days Range
$11.12 - $11.20
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
26,844,292
FINANCIAL STATEMENTS FOR OYSTER POINT PHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR OYSTER POINT PHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Nau JeffreyPresident and CEOJan 29, 2022 Option Exercise$11.702,60730,502148,713Jan 04, 2023, 05:06 PM
Lochner DanielChief Financial OfficerJan 29, 2022 Option Exercise$11.7093810,97576,525Jan 04, 2023, 05:04 PM
Nau JeffreyPresident and CEODec 01, 2022 Option Exercise$11.208,938100,106148,660Dec 06, 2022, 07:05 PM
Lochner DanielChief Financial OfficerDec 01, 2022 Option Exercise$11.203,25836,49074,463Dec 06, 2022, 08:50 AM
Nau JeffreyPresident and CEODec 01, 2022 Option Exercise$11.206,21769,630151,381Dec 05, 2022, 05:36 PM
Lochner DanielChief Financial OfficerNov 01, 2021 Option Exercise$11.518,59098,87158,221Nov 02, 2021, 05:49 PM
Nau JeffreyPresident and CEOOct 21, 2021 Option Exercise$1.0250,00051,000110,898Oct 22, 2021, 04:41 PM
Versant Venture Capital VI, L.P.10% OwnerOct 18, 2021 Sale$14.84550,0008,160,7361,057,976Oct 20, 2021, 04:38 PM
LINK WILLIAM J PHDDirectorOct 18, 2021 Sale$14.84550,0008,160,7361,057,976Oct 20, 2021, 04:32 PM
Ozawa ClareDirectorOct 18, 2021 Sale$14.84550,0008,160,7361,057,976Oct 20, 2021, 04:31 PM
Lochner DanielChief Financial OfficerSep 02, 2021 Option Exercise$11.517,50086,32549,631Sep 07, 2021, 08:03 AM
Nau JeffreyPresident and CEOSep 01, 2021 Option Exercise$1.0210,00010,20060,898Sep 01, 2021, 06:00 PM
Lochner DanielChief Financial OfficerJul 28, 2021 Option Exercise$11.517,50086,32542,131Jul 29, 2021, 05:05 PM
Nau JeffreyPresident and CEOApr 02, 2021 Option Exercise$1.0210,00010,20050,898Apr 02, 2021, 02:11 PM
Lochner DanielChief Financial OfficerFeb 24, 2021 Option Exercise$11.519,109104,84534,631Feb 26, 2021, 07:50 PM
Nau JeffreyPresident and CEOFeb 19, 2021 Option Exercise$1.0210,00010,20040,898Feb 23, 2021, 08:13 PM
Lochner DanielChief Financial OfficerSep 25, 2020 Option Exercise$11.514,00046,04014,300Sep 28, 2020, 06:12 PM
Lochner DanielChief Financial OfficerAug 11, 2020 Option Exercise$11.514,00046,04010,300Aug 18, 2020, 06:18 PM
Lochner DanielChief Financial OfficerAug 11, 2020 Option Exercise$11.514,00046,0404,000Aug 12, 2020, 08:32 PM
Snisarenko JohnChief Commercial OfficerAug 10, 2020 Buy$25.974,000103,8807,000Aug 11, 2020, 04:03 PM
Nau JeffreyPresident and CEOJul 28, 2020 Option Exercise$1.025,0005,1005,000Jul 30, 2020, 07:37 PM
InvOpps GP IV, L.L.C.DirectorMay 19, 2020 Buy$28.00178,5714,999,9881,850,818May 21, 2020, 05:00 PM
InvOpps GP IV, L.L.C.DirectorNov 04, 2019 Buy$16.00750,00012,000,0001,731,425Nov 06, 2019, 04:30 PM
Snisarenko JohnChief Commercial OfficerNov 04, 2019 Buy$16.003,00048,0003,000Nov 05, 2019, 06:08 AM
Lochner DanielChief Financial OfficerNov 04, 2019 Buy$16.006,300100,8006,300Nov 05, 2019, 06:08 AM
Nau JeffreyPresident and CEONov 04, 2019 Buy$16.001,00016,0001,000Nov 05, 2019, 06:05 AM
Vida Ventures, LLC10% OwnerNov 04, 2019 Buy$16.00185,0002,960,000963,468Nov 04, 2019, 07:04 PM
Falcon Vision LLC10% OwnerNov 04, 2019 Buy$16.00155,0002,480,0001,039,622Nov 04, 2019, 06:19 PM
KKR Fund Holdings L.P.10% OwnerNov 04, 2019 Buy$16.00155,0002,480,0001,039,622Nov 04, 2019, 06:17 PM
New Enterprise Associates 14, L.P.10% OwnerNov 04, 2019 Buy$16.00935,00014,960,0005,925,287Nov 04, 2019, 06:04 PM
Versant Venture Capital VI, L.P.10% OwnerNov 04, 2019 Buy$16.00437,5007,000,0001,003,658Nov 04, 2019, 05:58 PM
Versant Venture Capital VI, L.P.10% OwnerNov 04, 2019 Buy$16.00125,0002,000,0002,561,888Nov 04, 2019, 05:58 PM
Versant Venture Capital VI, L.P.10% OwnerNov 04, 2019 Buy$16.0027,500440,0002,002,298Nov 04, 2019, 05:58 PM
Ozawa ClareDirectorNov 04, 2019 Buy$16.00562,5009,000,0002,561,888Nov 04, 2019, 05:54 PM
LINK WILLIAM J PHDDirectorNov 04, 2019 Buy$16.0027,500440,0002,002,298Nov 04, 2019, 05:51 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Nau JeffreyPresident and CEO01/29/202230,502
Lochner DanielChief Financial Officer01/29/202210,975
Nau JeffreyPresident and CEO12/01/2022100,106
Lochner DanielChief Financial Officer12/01/202236,490
Nau JeffreyPresident and CEO12/01/202269,630
Lochner DanielChief Financial Officer11/01/202198,871
Nau JeffreyPresident and CEO10/21/202151,000
Versant Venture Capital VI, L.P.10% Owner10/18/20218,160,736
LINK WILLIAM J PHDDirector10/18/20218,160,736
Ozawa ClareDirector10/18/20218,160,736
Lochner DanielChief Financial Officer09/02/202186,325
Nau JeffreyPresident and CEO09/01/202110,200
Lochner DanielChief Financial Officer07/28/202186,325
Nau JeffreyPresident and CEO04/02/202110,200
Lochner DanielChief Financial Officer02/24/2021104,845
Nau JeffreyPresident and CEO02/19/202110,200
Lochner DanielChief Financial Officer09/25/202046,040
Lochner DanielChief Financial Officer08/11/202046,040
Lochner DanielChief Financial Officer08/11/202046,040
Snisarenko JohnChief Commercial Officer08/10/2020103,880
Nau JeffreyPresident and CEO07/28/20205,100
InvOpps GP IV, L.L.C.Director05/19/20204,999,988
InvOpps GP IV, L.L.C.Director11/04/201912,000,000
Snisarenko JohnChief Commercial Officer11/04/201948,000
Lochner DanielChief Financial Officer11/04/2019100,800
Nau JeffreyPresident and CEO11/04/201916,000
Vida Ventures, LLC10% Owner11/04/20192,960,000
Falcon Vision LLC10% Owner11/04/20192,480,000
KKR Fund Holdings L.P.10% Owner11/04/20192,480,000
New Enterprise Associates 14, L.P.10% Owner11/04/201914,960,000
Versant Venture Capital VI, L.P.10% Owner11/04/20197,000,000
Versant Venture Capital VI, L.P.10% Owner11/04/20192,000,000
Versant Venture Capital VI, L.P.10% Owner11/04/2019440,000
Ozawa ClareDirector11/04/20199,000,000
LINK WILLIAM J PHDDirector11/04/2019440,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR OYSTER POINT PHARMA INC
LOADING...